Cargando…
Putting PLX5622 into perspective: microglia in central nervous system viral infection
Autores principales: | Spiteri, Alanna G., King, Nicholas J.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838161/ https://www.ncbi.nlm.nih.gov/pubmed/36453408 http://dx.doi.org/10.4103/1673-5374.360170 |
Ejemplares similares
-
PLX5622 Reduces Disease Severity in Lethal CNS Infection by Off-Target Inhibition of Peripheral Inflammatory Monocyte Production
por: Spiteri, Alanna G., et al.
Publicado: (2022) -
Significant Sex Differences in the Efficacy of the CSF1R Inhibitor-PLX5622 on Rat Brain Microglia Elimination
por: Sharon, Aviv, et al.
Publicado: (2022) -
Terminal field volume of the glossopharyngeal nerve in adult rats reverts to prepruning size following microglia depletion with PLX5622
por: Riquier, Andrew J., et al.
Publicado: (2022) -
Low-dose PLX5622 treatment prevents neuroinflammatory and neurocognitive sequelae after sepsis
por: Mein, Nils, et al.
Publicado: (2023) -
CSF1R inhibitor PLX5622 and environmental enrichment additively improve metabolic outcomes in middle-aged female mice
por: Ali, Seemaab, et al.
Publicado: (2020)